Enchi Liu

Enchi Liu has over 20 years of experience in the biopharmaceutical industry. Enchi began their career in 1995 as a Postdoctoral Research Associate at the University of Arizona, where they investigated CNS development in Drosophila. In 1998, they joined Quintiles as a Senior Specialist, Medical & Scientific Services and Clinical Research Associate. In 2001, they joined Hologic (formerly Gen-Probe) as a Clinical Scientist and Elan Pharmaceuticals, Inc. as a Senior Director, Clinical Development. In 2009, they joined Janssen Alzheimer Immunotherpay Research and Development as a Senior Director, Clinical Development. In 2013, they joined Janssen Inc. as a Senior Director, Neuroscience Biomarkers, and in 2015 they joined Prothena Biosciences, Inc. as a Program Team Leader. In 2019, they joined E-Scape Bio as Head of Clinical Development and Translational Biomarkers and Annexon Biosciences as VP Global Program Team Leader. Enchi is currently VP Translational Sciences at Tranquis Therapeutics, Inc.

Enchi Liu obtained a Bachelor of Arts - BA in Neurobiology and Behavior from Cornell University, followed by a Doctor of Philosophy - PhD in Neurobiology and Behavior from the same institution.